Notícias e Atividades da ViiV Healthcare

A ViiV Healthcare pertence à GSK.

GSK é uma das ...

• Forbes Global 2000 (#236);
• Fortune 500 Europe (#104);
• FTSE 350;
• Global Fortune 500 (#388);
• Stoxx 600;
• TOB Iconic 10,000.

GSK é uma empresa listada sob o símbolo GSK (GB).

GSK tem presença direta em 21 países.

GSK possui 25 subsidiárias incluindo GSK ANZ, GSK APAC e GSK Austria.

Fusão, aquisição e financiamento envolvendo GSK.

• GSK has announced the acquisition of Rapt Therapeutics  (publicado em 21 de janeiro de 2026).
• IDRx and GSK have merged  (publicado em 24 de fevereiro de 2025)..
• GSK has announced the acquisition of IDRx  (publicado em 13 de janeiro de 2025).

Veja o organograma con seus 17 executivos principais

Biografias mais buscadas da ViiV Healthcare

• Deborah Waterhouse, Chief Executive Officer and Director
• Regis Simard, Director
• David Redfern, Chairman of the Board

Recentes movimentos de executivos em ViiV Healthcare

• Kimberly Smith, Head of Head of Research and Development, deixou a Companhia  (Notícia publicada em 31 de março de 2026).
• Charlotte Allerton antes Board Member, agora é Head of Research and Development  (Notícia publicada em 31 de março de 2026).

Recentes movimentos de executivos em GSK

• Roanne Parry, ingressou na Companhia como Chief People Officer  (Notícia publicada em 4 de maio de 2026).
• Diana Conrad, Chief People Officer, deixou a Companhia  (Notícia publicada em 4 de maio de 2026).
• Sally Jackson, Senior Vice President, Global Communications, deixou a Companhia  (Notícia publicada em 7 de abril de 2026).

Clique aqui para ver outras movimentos em GSK

Criar um alerta
para seguir os movimentos de executivos da ViiV Healthcare.

GSK possui 1.913 concorrentes concorrentes Sanofi (França), Eli Lilly (Estados Unidos) e Moderna (Estados Unidos).

Popular M&A news in Farmacêutica

• Corden Pharma has announced the acquisition of AmbioPharm  (publicado em 5 de junho de 2026).
• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (publicado em 4 de junho de 2026).
• Contraline acaba de anunciar uma arrecadação de fundos de 93 milhões de dólares. (publicado em 3 de junho de 2026).

Outros contatos sugeridos na indústria do Farmacêutica

• Joaquin Duato - Chief Executive Officer and Chairman of the Board da Johnson & Johnson
• Robert Ford - Chief Executive Officer and Chairman of the Board da Abbott
• Richard Saynor - Chief Executive Officer da Sandoz

Saiba mais sobre a indústria do Farmacêutica

Últimos comunicados de imprensa de ViiV Healthcare

• ViiV Healthcare announces new strategic alliance to enable greater access to antiretroviral medicines in Brazil
• ViiV Healthcare announces superior efficacy of investigational, long-acting injectable formulation of cabotegravir dosed every two months over daily oral PrEP
• ViiV Healthcare presents positive data from first-ever implementation research study on how best to integrate a investigational once-monthly injectable HIV treatment in US healthcare practices
• ViiV Healthcare shares new data from Positive Perspectives, Wave 2 study, confirming a more holistic approach to HIV care can improve quality of life
• ViiV Healthcare announces US FDA approval for Rukobia (fostemsavir), a first-in-class treatment for HIV in adults with few treatment options available
• ViiV Healthcare to present new data on long-acting regimens for HIV prevention and treatment, alongside extensive insights into the evolving needs of people living with HIV at 23rd International AIDS Conference (AIDS 2020: Virtual)
• ViiV Healthcare announces grantees selected as part of £3 million Fund dedicated to HIV research and community-based programmes during COVID-19 pandemic
• Welsh Rugby star Gareth Thomas and ViiV Healthcare launch Tackle HIV campaign to address public misunderstanding and stigma associated with HIV
• Global HIV prevention study to stop early after ViiV Healthcare’s long-acting injectable formulation of cabotegravir dosed every two months shows higher efficacy than daily oral PrEP
• ViiV Healthcare announces £3 million global fund to research the impact of COVID-19 on the HIV community and fill gaps in prevention, treatment and care during the pandemic
• View more press releases Close

Redes sociais sobre ViiV Healthcare

• ViiV Healthcare na Wikipedia, Google News e Yahoo Finance
• ViiV Healthcare na LinkedIn, X (Twitter) e YouTube